Concepedia

Publication | Closed Access

Prognostic Significance of Lymphocyte Counts in Colon Cancer Patients Treated with FOLFOX Chemotherapy

32

Citations

22

References

2017

Year

Abstract

Lymphocyte count during chemotherapy is a strong predictor of worse disease-free survival in colon cancer patients who have undergone FOLFOX adjuvant chemotherapy.

References

YearCitations

Page 1